# Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With VVA

> **NCT04222647** · PHASE2 · COMPLETED · sponsor: **Dr. August Wolff GmbH & Co. KG Arzneimittel** · enrollment: 43 (actual)

## Conditions studied

- Vulvovaginal Atrophy

## Interventions

- **DRUG:** WO533

## Key facts

- **NCT ID:** NCT04222647
- **Lead sponsor:** Dr. August Wolff GmbH & Co. KG Arzneimittel
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-27
- **Primary completion:** 2020-08-11
- **Final completion:** 2020-08-11
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2021-12-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04222647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04222647, "Investigation of Efficacy and Tolerability of a Lactic Acid Containing Vaginal Suppository in Post-menopausal Women With VVA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04222647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*